Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hereditary Cancer Syndrome clinical trials
5 of 5 indexed Hereditary Cancer Syndrome trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Hereditary Cancer Syndrome: 5 US clinical trials tracked, 5 recruiting.
Hereditary Cancer Syndrome is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is San Raffaele University, running 1 of these trials.
Enrollment posture brief
Registry condition hereditary-cancer-syndrome
OPEN 5 | RECR 100% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Hereditary Cancer Syndrome lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hereditary Cancer Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hereditary Cancer Syndrome is recruiting above its size-band peers.
5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hereditary Cancer Syndrome research.
San Raffaele University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Hereditary Cancer Syndrome enrolment sits around 300 participants.
Median target enrolment is 300 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Hereditary Cancer Syndrome splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Dana-Farber Cancer Institute
NCT04541654
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening
Columbia University
NCT07195071
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
San Raffaele University
NCT06708429
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Weill Medical College of Cornell University
NCT05562778
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
University of Illinois at Chicago
NCT05664867
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Hereditary Cancer Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hereditary Cancer Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hereditary Cancer Syndrome page
5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Hereditary Cancer Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- San Raffaele University sponsors the most Hereditary Cancer Syndrome trials on record, review their full trial history before evaluating a specific study. See San Raffaele University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hereditary Cancer Syndrome condition card totals 5 registered trials; most-linked intervention Enhanced Standard of Care Model; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.